Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Axonics Modulation Technologies brings in $32.6mm through Series A round

Executive Summary

Axonics Modulation Technologies Inc. (implantable neuromodulation technology) raised $32.6mm via its Series A financing of preferred shares led by Edmond de Rothschild Investment Partners. NeoMed Management, Legend Capital, and private investors also participated. A member from each investment firm takes a seat on Axonics’ board.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Implantable Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies